Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOMP olaparib maintenance trial in small cell lung cancer
ISRCTN73164486Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jan 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in small cell lung cancer (SCLC) comparing Olaparib maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival time. Started Jan 2011; status: completed.
02
Drugs
olaparib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on ISRCTN73164486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73164486.